Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MultiCell Technologies
AddedFeb 20, 2024
UpdatedJun 18, 2026
MultiCell Technologies

MultiCell Technologies

Public

US-based MultiCell Technologies develops immune-modulating therapies, antiviral treatments, and cell lines for drug discovery.

HQ
Woonsocket, RI, US
Founded
1970
Overview
Compare
Employees

MultiCell Technologies is a biotechnology company focused on developing immune-modulating therapies and antiviral treatments to combat influenza and other infectious diseases. The company also produces cell lines used by pharmaceutical companies for drug screening and development.

MultiCell Technologies has made significant strides in the biotech industry by providing essential tools for drug discovery and advancing therapeutic candidates. Their contributions have facilitated the development of new drugs and treatments, impacting both pharmaceutical research and patient care.

MultiCell Technologies - Similar Companies

ExpressCells logo

ExpressCells

Cellular Approaches logo

Cellular Approaches

Cellworks logo

Cellworks

Multispan logo

Multispan

multispaninc.com

Celltheon logo

Celltheon

celltheon.com

Cel-Sci logo

Cel-Sci

cel-sci.com

Retrovirox logo

Retrovirox

retrovirox.com

MelliCell logo

MelliCell

mellicell.com

Spheringenics logo

Spheringenics

Cellomics Technology logo

Cellomics Technology

cellomicstech.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Cellular Engineering Technologies logo

Cellular Engineering Technologies

celleng-tech.com

Celularity logo

Celularity

celularity.com

Cellix Bio logo

Cellix Bio

Kincell Bio logo

Kincell Bio

kincellbio.com

MultiCell Technologies - Quick Facts

Who are MultiCell Technologies' competitors?

Companies similar to MultiCell Technologies include ExpressCells, Cellular Approaches, Cellworks and Multispan.

When was MultiCell Technologies founded?

MultiCell Technologies was founded in 1970.

Where is MultiCell Technologies' headquarters located?

MultiCell Technologies' headquarters is located in Woonsocket, RI, US.

How many employees does MultiCell Technologies have?

MultiCell Technologies has 2 employees as of Feb 5, 2024.

MultiCell Technologies - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antivirals
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 44 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 332000Fabricated Metal Product Manufacturing
  • 332900Other Fabricated Metal Product Manufacturing
  • 332990All Other Fabricated Metal Product Manufacturing
  • 332994Small Arms, Ordnance, and Ordnance Accessories Manufacturing
  • 333200Industrial Machinery Manufacturing
  • 333240Industrial Machinery Manufacturing
  • 333248All Other Industrial Machinery Manufacturing
  • 333400Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing
  • 333410Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing
  • 333415Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing
  • 333900Other General Purpose Machinery Manufacturing
  • 333990All Other General Purpose Machinery Manufacturing
  • 333994Industrial Process Furnace and Oven Manufacturing
  • 333998All Other Miscellaneous General Purpose Machinery Manufacturing
  • 337000Furniture and Related Product Manufacturing
  • 337100Household and Institutional Furniture and Kitchen Cabinet Manufacturing
  • 337120Household and Institutional Furniture Manufacturing
  • 337127Institutional Furniture Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 339113Surgical Appliance and Supplies Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 333000Machinery Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2520Manufacture of weapons and ammunition
  • 2815Manufacture of ovens, furnaces and furnace burners
  • 3250Manufacture of medical and dental instruments and supplies